These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22027751)

  • 21. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
    Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
    Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel node mapping with indocyanine green and endoscopic near-infrared fluorescence imaging in endometrial cancer. A pilot study and review of the literature.
    Plante M; Touhami O; Trinh XB; Renaud MC; Sebastianelli A; Grondin K; Gregoire J
    Gynecol Oncol; 2015 Jun; 137(3):443-7. PubMed ID: 25771495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnostic value of optical imaging combined with indocyanine green-guided sentinel lymph node biopsy in gastric cancer: a meta-analysis].
    He MF; Jiang ZW; Hao ZW; An J; Zhai J; Shen JK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1196-1204. PubMed ID: 31874538
    [No Abstract]   [Full Text] [Related]  

  • 24. Sentinel Lymph Node Biopsy in Vulvar Cancer Using Combined Radioactive and Fluorescence Guidance.
    Verbeek FP; Tummers QR; Rietbergen DD; Peters AA; Schaafsma BE; van de Velde CJ; Frangioni JV; van Leeuwen FW; Gaarenstroom KN; Vahrmeijer AL
    Int J Gynecol Cancer; 2015 Jul; 25(6):1086-93. PubMed ID: 25768079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of sentinel lymph node mapping in bladder cancer using near-infrared fluorescence imaging.
    Schaafsma BE; Verbeek FP; Elzevier HW; Tummers QR; van der Vorst JR; Frangioni JV; van de Velde CJ; Pelger RC; Vahrmeijer AL
    J Surg Oncol; 2014 Dec; 110(7):845-50. PubMed ID: 25111761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sentinel lymph node mapping using indocyanine green in patients with uterine and cervical neoplasms: restrictions of the method.
    Bedyńska M; Szewczyk G; Klepacka T; Sachadel K; Maciejewski T; Szukiewicz D; Fijałkowska A
    Arch Gynecol Obstet; 2019 May; 299(5):1373-1384. PubMed ID: 30762108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
    Salvo G; Ramirez PT; Levenback CF; Munsell MF; Euscher ED; Soliman PT; Frumovitz M
    Gynecol Oncol; 2017 Apr; 145(1):96-101. PubMed ID: 28188015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Comparison of Radiocolloid and Indocyanine Green Fluorescence Imaging, Sentinel Lymph Node Mapping in Patients with Cervical Cancer Undergoing Laparoscopic Surgery.
    Imboden S; Papadia A; Nauwerk M; McKinnon B; Kollmann Z; Mohr S; Lanz S; Mueller MD
    Ann Surg Oncol; 2015 Dec; 22(13):4198-203. PubMed ID: 26122376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm).
    Di Martino G; Crivellaro C; De Ponti E; Bussi B; Papadia A; Zapardiel I; Vizza E; Elisei F; Diestro MD; Locatelli L; Gasparri ML; Di Lorenzo P; Mueller M; Buda A
    J Minim Invasive Gynecol; 2017; 24(6):954-959. PubMed ID: 28571944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial.
    Frumovitz M; Plante M; Lee PS; Sandadi S; Lilja JF; Escobar PF; Gien LT; Urbauer DL; Abu-Rustum NR
    Lancet Oncol; 2018 Oct; 19(10):1394-1403. PubMed ID: 30143441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001).
    Taşkın S; Altin D; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Kahramanoglu I; Naki MM; Güngör M; Köse F; Ortac F; Arvas M; Ayhan A; Taskiran C
    Int J Gynecol Cancer; 2020 Mar; 30(3):299-304. PubMed ID: 31857440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From Conventional Radiotracer Tc-99(m) with Blue Dye to Indocyanine Green Fluorescence: A Comparison of Methods Towards Optimization of Sentinel Lymph Node Mapping in Early Stage Cervical Cancer for a Laparoscopic Approach.
    Buda A; Papadia A; Zapardiel I; Vizza E; Ghezzi F; De Ponti E; Lissoni AA; Imboden S; Diestro MD; Verri D; Gasparri ML; Bussi B; Di Martino G; de la Noval BD; Mueller M; Crivellaro C
    Ann Surg Oncol; 2016 Sep; 23(9):2959-65. PubMed ID: 27126631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Near-infrared fluorescence sentinel lymph node detection in gastric cancer: A pilot study.
    Tummers QR; Boogerd LS; de Steur WO; Verbeek FP; Boonstra MC; Handgraaf HJ; Frangioni JV; van de Velde CJ; Hartgrink HH; Vahrmeijer AL
    World J Gastroenterol; 2016 Apr; 22(13):3644-51. PubMed ID: 27053856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel lymph node detection rates using indocyanine green in women with early-stage cervical cancer.
    Beavis AL; Salazar-Marioni S; Sinno AK; Stone RL; Fader AN; Santillan-Gomez A; Tanner EJ
    Gynecol Oncol; 2016 Nov; 143(2):302-306. PubMed ID: 27526991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative PET/CT lymphoscintigraphy and fluorescent real-time imaging for sentinel lymph node mapping in early staged colon cancer.
    Ankersmit M; Hoekstra OS; van Lingen A; Bloemena E; Jacobs MAJM; Vugts DJ; Bonjer HJ; van Dongen GAMS; Meijerink WJHJ
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1495-1505. PubMed ID: 30798428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer sentinel lymph node mapping using near infrared guided indocyanine green and indocyanine green--human serum albumin in comparison with gamma emitting radioactive colloid tracer.
    Polom K; Murawa D; Nowaczyk P; Rho YS; Murawa P
    Eur J Surg Oncol; 2012 Feb; 38(2):137-42. PubMed ID: 22130469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Prospective Cohort Study Comparing Colorimetric and Fluorescent Imaging for Sentinel Lymph Node Mapping in Endometrial Cancer.
    Holloway RW; Ahmad S; Kendrick JE; Bigsby GE; Brudie LA; Ghurani GB; Stavitzski NM; Gise JL; Ingersoll SB; Pepe JW
    Ann Surg Oncol; 2017 Jul; 24(7):1972-1979. PubMed ID: 28265777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of near-infrared fluorescent sentinel lymph node mapping for vulvar cancer.
    Hutteman M; van der Vorst JR; Gaarenstroom KN; Peters AA; Mieog JS; Schaafsma BE; Löwik CW; Frangioni JV; van de Velde CJ; Vahrmeijer AL
    Am J Obstet Gynecol; 2012 Jan; 206(1):89.e1-5. PubMed ID: 21963099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraoperative Fluorescence Imaging for Sentinel Lymph Node Detection: Prospective Clinical Trial to Compare the Usefulness of Indocyanine Green vs Technetium Tc 99m for Identification of Sentinel Lymph Nodes.
    Stoffels I; Dissemond J; Pöppel T; Schadendorf D; Klode J
    JAMA Surg; 2015 Jul; 150(7):617-23. PubMed ID: 26017057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.